Subscribe to
this category


A total of 52 posts are filed under Deals
Orchard Therapeutics Acquires GSK’s Gene Therapy Portfolio
Rare Daily Staff GSK will said it will transfer its portfolio of approved and investigational rare disease gene therapies to Orchard… Continue Reading
Alexion To Acquire Wilson Therapeutics for $855 million
Rare Daily Staff Alexion Pharmaceuticals said it will acquire Stockholm-based rare disease drug developer Wilson Therapeutics through an… Continue Reading
Novo Nordisk to Pay $400 Million to License EpiDestiny’s Sickle Cell Disease Program
Rare Daily Staff Novo Nordisk agreed to pay an upfront fee of $400 million for an exclusive worldwide license for EpiDestiny program EPI01… Continue Reading
Novartis Agrees to Acquire Gene Therapy Developer AveXis for $8.7 Billion
Rare Daily Staff Drug giant Novartis agreed to acquire gene therapy developer AveXis for $8.7 billion or $218 per share in cash. The offer… Continue Reading
Takeda Considering Acquiring Shire
Rare Daily Staff  The Japanese-based drug giant Takeda Pharmaceutical issued a statement confirming that it is considering a bid to acquire… Continue Reading
Shire and NanoMedSyn Enter into Research Collaboration for Lysosomal Storage Disorder Treatment
Shire and NanoMedSyn Enter into Research Agreement for Potential Lysosomal Storage Disorder Treatment Rare Daily Staff Shire said it entered… Continue Reading
Ionis and Akcea Form hATTR Partnership Worth up to $1.7 Billion
Rare Daily Staff Akcea Therapeutics, an affiliate of Ionis Pharmaceuticals, entered into an exclusive, worldwide agreement to license… Continue Reading
1 2 3 8